HS
HeartSciences Inc.
HSCSW · NASDAQ
$0.07 +0.15% (+$0.00)
1M +18.02%
Market Cap $180.3K
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$0.1
46.8% upside
Current Price
$0.068
Undervalued Fair Value Overvalued
According to Bulios Fair Price, HSCSW is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Weak
2/9Valuation
100 /100
Cheap P/S 0.09x
EV/EBITDA N/A
P/B N/A
Growth
0 /100
Declining Rev. growth 32.86%
FCF growth N/A
Book val. growth N/A
Profitability
20 /100
Weak Net margin 151,227.00%
Op. margin 140,107.00%
FCF margin 62,993.00%
Quality
0 /100
Poor ROA 85.08%
Asset turnover 0.00x
ROIC 149.42%
Debt
0 /100
High Int. coverage 0.03x
Current ratio 0.14x
Net debt/EBITDA N/A
Stability
2 /100
Unstable Rev. volatility 191.53%
EPS volatility 2,569.73%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about HSCSW
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Andrew Simpson
Employees
14
Headquarters
Southlake
Upcoming events
10 DEC
Earnings
Upcoming earnings report